Cello Health acquires Mash Health inc

Cello Group plc, the insight and strategic marketing group, announces the acquisition of Mash Health Limited and Mash Health, Inc. Initial consideration is approximately £0.6 million, with further performance related consideration of up to a maximum of £0.9 million.

Mash specialises in providing consultancy and communications services to pharmaceutical, nutraceutical and consumer healthcare clients. Core clients include Reckitt Benckiser, GSK, BMS, Bayer, J&J and Danone.

Mash was established by Jane Ayton and Marianne MacDonald in 2009 and is based in London and New Jersey. In 2012, its first year of entering the Communiqué Awards, Mash won the Pharmaceutical Marketing Excellence Award for Education.

Mash will join Cello’s healthcare division, Cello Health, and will further complement Cello Health’s insight, advisory and evidence based capabilities in the ethical pharmaceutical area, with enhanced expertise in the consumer health area. This is consistent with Cello Health’s aim of becoming a leading global health services company. >> source Cello website <<